DOI QR코드

DOI QR Code

Outcome of Pandemic H1N1 Pneumonia: Clinical and Radiological Findings for Severity Assessment

  • Cho, Woo-Hyun (Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Kim, Yun-Seong (Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Jeon, Doo-Soo (Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Kim, Ji-Eun (Department of Internal Medicine, Pusan National University Yangsan Hospital) ;
  • Kim, Kun-Il (Department of Radiology, Pusan National University Yangsan Hospital) ;
  • Seol, Hee-Yun (Department of Internal Medicine, Pusan National University Hospital) ;
  • Kim, Ki-Uk (Department of Internal Medicine, Pusan National University Hospital) ;
  • Park, Hye-Kyung (Department of Internal Medicine, Pusan National University Hospital) ;
  • Lee, Min-Ki (Department of Internal Medicine, Pusan National University Hospital) ;
  • Park, Soon-Kew (Department of Internal Medicine, Pusan National University Hospital) ;
  • Jeong, Yeon-Joo (Department of Radiology, Pusan National University Hospital)
  • Published : 2011.06.01

Abstract

Background/Aims: Pandemic influenza A (H1N1) virus infection presents with variable severity. However, little is known about clinical predictors of disease severity. We studied the clinical predictors of severe pandemic H1N1 pneumonia and their correlation with radiological findings. Methods: We reviewed medical and radiological records of adults with pandemic H1N1 pneumonia. After classification of patients into severe and non-severe groups, the following data were evaluated: demographic data, pneumonia severity index (PSI), CURB65, risk factors, time to first dose of antiviral medication, routine laboratory data, clinical outcome, and radiological characteristics. Results: Of 37 patients with pandemic H1N1 pneumonia, 12 and 25 were assigned to the severe and non-severe groups, respectively. PSI score, serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dyhydrogenase (LDH) levels were higher in the severe group than in the non-severe group (p = 0.035, 0.0003, 0.0023, and 0.0002, respectively). AST, ALT, and LDH levels were positively correlated with the radiological findings (p < 0.0001, 0.0003, and < 0.0001, respectively) and with the number of involved lobes (p = 0.663, 0.0134, and 0.0019, respectively). The most common finding on high resolution computed tomography (HRCT) scans was ground-glass attenuation with consolidation (n = 22, 60%), which had a predominantly patchy distribution (n = 31). Conclusions: We demonstrated a positive correlation between clinical findings, such as serum AST, ALT, and LDH levels, and radiological findings. A combination of clinical and HRCT indicators would be useful in predicting the clinical outcome of pandemic H1N1 pneumonia.

Keywords

References

  1. Centers for Disease Control and Prevention (CDC). Swine influenza A (H1N1) infection in two children: Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 2009;58:400-402.
  2. Centers for Disease Control and Prevention (CDC). Update: influenza activity: United States, August 30-October 31, 2009. MMWR Morb Mortal Wkly Rep 2009;58:1236-1241.
  3. Centers for Disease Control and Prevention (CDC). Hospitalized patients with novel influenza A (H1N1) virus infection: California, April-May, 2009. MMWR Morb Mortal Wkly Rep 2009;58:536-541.
  4. Human infection with pandemic A (H1N1) 2009 influenza virus: clinical observations in hospitalized patients, Americas, July 2009 - update. Wkly Epidemiol Rec 2009;84:305-308.
  5. Epidemiological summary of pandemic influenza A (H1N1) 2009 virus: Ontario, Canada, June 2009. Wkly Epidemiol Rec 2009;84:485-491.
  6. Centers for Disease Control and Prevention (CDC). Patients hospitalized with 2009 pandemic influenza A (H1N1): New York City, May 2009. MMWR Morb Mortal Wkly Rep 2010;58:1436-1440.
  7. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009;361:680-689. https://doi.org/10.1056/NEJMoa0904252
  8. Rello J, Rodriguez A, Ibanez P, et al. Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1)v in Spain. Crit Care 2009;13:R148. https://doi.org/10.1186/cc8044
  9. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009;302:1872-1879. https://doi.org/10.1001/jama.2009.1496
  10. Dominguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009;302:1880-1887. https://doi.org/10.1001/jama.2009.1536
  11. Chien YS, Su CP, Tsai HT, et al. Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan. J Infect 2010;60:168-174. https://doi.org/10.1016/j.jinf.2009.12.012
  12. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44 Suppl 2:S27-S72.
  13. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-250. https://doi.org/10.1056/NEJM199701233360402
  14. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-382. https://doi.org/10.1136/thorax.58.5.377
  15. Fisman DN, Savage R, Gubbay J, et al. Older age and a reduced likelihood of 2009 H1N1 virus infection. N Engl J Med 2009;361:2000-2001. https://doi.org/10.1056/NEJMc0907256
  16. Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009;302:1896-1902. https://doi.org/10.1001/jama.2009.1583
  17. Vaillant L, La Ruche G, Tarantola A, Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 2009;14:19309.
  18. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections: the MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Lancet 1998;352:1877-1881. https://doi.org/10.1016/S0140-6736(98)10190-3
  19. Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000;355:1845-1850. https://doi.org/10.1016/S0140-6736(00)02288-1
  20. Jefferson T, Demicheli V, Rivetti D, Jones M, Di Pietrantonj C, Rivetti A. Antivirals for influenza in healthy adults: systematic review. Lancet 2006;367:303-313. https://doi.org/10.1016/S0140-6736(06)67970-1
  21. Chalmers JD, Singanayagam A, Hill AT. Predicting the need for mechanical ventilation and/or inotropic support for young adults admitted to the hospital with community-acquired pneumonia. Clin Infect Dis 2008;47:1571-1574. https://doi.org/10.1086/593195
  22. Kim EA, Lee KS, Primack SL, et al. Viral pneumonias in adults: radiologic and pathologic findings. Radiographics 2002;22 Spec No:S137-S149.
  23. Lee CW, Seo JB, Song JW, et al. Pulmonary complication of novel influenza A (H1N1) infection: imaging features in two patients. Korean J Radiol 2009;10:531-534. https://doi.org/10.3348/kjr.2009.10.6.531
  24. Agarwal PP, Cinti S, Kazerooni EA. Chest radiographic and CT findings in novel swine-origin influenza A (H1N1) virus (S-OIV) infection. AJR Am J Roentgenol 2009;193:1488-1493. https://doi.org/10.2214/AJR.09.3599
  25. Ajlan AM, Quiney B, Nicolaou S, Muller NL. Swine-origin influenza A (H1N1) viral infection: radiographic and CT findings. AJR Am J Roentgenol 2009;193:1494-1499. https://doi.org/10.2214/AJR.09.3625
  26. Marchiori E, Zanetti G, Hochhegger B, et al. High-resolution computed tomography findings from adult patients with Influenza A (H1N1) virus-associated pneumonia. Eur J Radiol 2010;74:93-98. https://doi.org/10.1016/j.ejrad.2009.11.005
  27. Centers for Disease Control and Prevention (CDC). Intensive-care patients with severe novel influenza A (H1N1) virus infection: Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009;58:749-752.
  28. Schultz MJ, Haitsma JJ, Zhang H, Slutsky AS. Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia: a review. Crit Care Med 2006;34:871-877.
  29. van Wissen M, Keller TT, Ronkes B, et al. Influenza infection and risk of acute pulmonary embolism. Thromb J 2007;5:16.
  30. Johkoh T, Itoh H, Muller NL, et al. Crazy-paving appearance at thin-section CT: spectrum of disease and pathologic findings. Radiology 1999;211:155-160.
  31. Kim KI, Lee KN, Tomiyama N, et al. Near drowning: thin-section CT findings in six patients. J Comput Assist Tomogr 2000;24:562-566. https://doi.org/10.1097/00004728-200007000-00009

Cited by

  1. Neurologic Complications and Outcomes of Pandemic (H1N1) 2009 in Korean Children vol.27, pp.4, 2011, https://doi.org/10.3346/jkms.2012.27.4.402
  2. Neurologic Complications and Outcomes of Pandemic (H1N1) 2009 in Korean Children vol.27, pp.4, 2011, https://doi.org/10.3346/jkms.2012.27.4.403
  3. Chest radiological findings of influenza A H1N1 pneumonia vol.18, pp.3, 2011, https://doi.org/10.1016/j.rppnen.2011.12.006
  4. Computed Tomography Findings of Influenza A (H1N1) Pneumonia in Adults: Pattern Analysis and Prognostic Comparisons vol.36, pp.3, 2011, https://doi.org/10.1097/rct.0b013e31825588e6
  5. Influenza A (H1N1) Pneumonia: A Review and Update vol.19, pp.6, 2012, https://doi.org/10.1097/cpm.0b013e318271cf14
  6. Influenza pneumonia among adolescents and adults: a concurrent comparison between influenza A (H1N1) pdm09 and A (H3N2) in the post-pandemic period vol.8, pp.2, 2011, https://doi.org/10.1111/crj.12056
  7. Predictive factors of severe multilobar pneumonia and shock in patients with influenza vol.31, pp.4, 2011, https://doi.org/10.1136/emermed-2012-202081
  8. Acute Pericarditis with Pericardial Effusion That Developed after Swine Influenza A (H1N1) Infection in a Healthy Adult vol.87, pp.4, 2014, https://doi.org/10.3904/kjm.2014.87.4.461
  9. Risk factors associated with mortality in patients infected with influenza A/H1N1 in Mexico vol.8, pp.None, 2015, https://doi.org/10.1186/s13104-015-1349-8
  10. Thin-section Computed Tomography Detects Long-term Pulmonary Sequelae 3 Years after Novel Influenza A Virus-associated Pneumonia vol.128, pp.7, 2015, https://doi.org/10.4103/0366-6999.154285
  11. The influence of comorbid factors in surviving of patients with severe form of seasonal influenza vol.62, pp.1, 2016, https://doi.org/10.33320/maced.pharm.bull.2016.62.01.005
  12. Factors Associated with Lethal Outcome in Patients with Severe Form of Influenza vol.37, pp.2, 2011, https://doi.org/10.1515/prilozi-2016-0018
  13. The high frequency of non-aspartic acid residues at HA222 in influenza A(H1N1) 2009 pandemic viruses is associated with mortality during the upsurge of 2015: a molecular and epidemiological study from vol.145, pp.13, 2011, https://doi.org/10.1017/s0950268817001595
  14. Molecular and epidemiological analysis of pandemic and post‐pandemic influenza A(H1N1)pdm09 virus from central India vol.90, pp.3, 2011, https://doi.org/10.1002/jmv.24982
  15. The Impact of Pneumonia on the Course and Outcome in Patients with Seasonal Influzenza vol.41, pp.2, 2011, https://doi.org/10.2478/prilozi-2020-0034
  16. Comparison of the computed tomography findings in COVID-19 and other viral pneumonia in immunocompetent adults: a systematic review and meta-analysis vol.30, pp.12, 2020, https://doi.org/10.1007/s00330-020-07018-x
  17. Clinical Characteristics and Prognostic Analysis of Microscopic Polyangiitis With Diffuse Alveolar Hemorrhage vol.48, pp.3, 2011, https://doi.org/10.3899/jrheum.191042
  18. Is COVID-19-induced liver injury different from other RNA viruses?‎ vol.9, pp.2, 2021, https://doi.org/10.13105/wjma.v9.i2.108
  19. Correlation between chest CT severity score and laboratory indicators in patients with Coronavirus disease 2019 (COVID‐19) vol.75, pp.12, 2011, https://doi.org/10.1111/ijcp.14907